Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06245044 · ClinicalTrials.gov registry record · NA
Preventing Medication Dispensing Errors in Pharmacy Practice With Interpretable Machine Intelligence
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT06245044: Completed NA study, sponsored by University of Michigan.
NCT06245044 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06245044, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
Pharmacists currently perform an independent double-check to identify drug-selection errors before they can reach the patient. However, the use of machine intelligence (MI) to support this cognitive decision-making work by pharmacists does not exist in practice. This research is being conducted to examine the effectiveness of the timing of machine intelligence (MI) advice on to determine if it results in lower task time, increased accuracy, and increased trust in the MI.
Primary Outcome
Difference in task time measured by the number of seconds from starting the task to accepting or rejecting a medication image
Interventions
- BEHAVIORAL No MI Help
- BEHAVIORAL Scenario #1
- BEHAVIORAL Scenario #2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2024-04-11 |
| Est. Completion | 2024-12-04 |
| Phase | NA |
What the finished NCT06245044 record still lists
NCT06245044 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which No MI Help is the first listed.
NCT06245044 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06245044 about?
NCT06245044 is a clinical study titled "Preventing Medication Dispensing Errors in Pharmacy Practice With Interpretable Machine Intelligence". Pharmacists currently perform an independent double-check to identify drug-selection errors before they can reach the patient. However, the use of machine intelligence (MI) to support this cognitive decision-making work by pharmacists does not exist in practice. This research is being conducted to e...
What is the current status of trial NCT06245044?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2024-04-11. Estimated completion is 2024-12-04.
What interventions are being tested in trial NCT06245044?
The interventions under investigation include: No MI Help (BEHAVIORAL), Scenario #1 (BEHAVIORAL), Scenario #2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT06245044?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06245044's enrollment target sits among peer trials
68 1133rd of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI